|
RBAK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.17700000001886E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.86830000000238E-05 |
| Normal-vs-Stage2 |
7.020000E-02 |
| Normal-vs-Stage3 |
2.476200E-01 |
| Normal-vs-Stage4 |
5.208200E-01 |
| Stage1-vs-Stage2 |
7.361000E-01 |
| Stage1-vs-Stage3 |
2.033800E-01 |
| Stage1-vs-Stage4 |
6.084300E-02 |
| Stage2-vs-Stage3 |
2.751800E-01 |
| Stage2-vs-Stage4 |
1.708600E-01 |
| Stage3-vs-Stage4 |
7.120800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81638999999789E-05 |
| Normal-vs-AfricanAmerican |
2.800700E-03 |
| Normal-vs-Asian |
6.874800E-01 |
| Caucasian-vs-AfricanAmerican |
8.263000E-01 |
| Caucasian-vs-Asian |
6.392400E-02 |
| AfricanAmerican-vs-Asian |
6.867600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.67940000000267E-05 |
| Normal-vs-Female |
4.24460000000293E-05 |
| Male-vs-Female |
1.428180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.364100E-02 |
| Normal-vs-Extreme_Weight |
9.204700E-03 |
| Normal-vs-Obese |
2.183900E-04 |
| Normal-vs-Extreme_Obese |
2.245000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.653400E-01 |
| Normal_Weight-vs-Obese |
1.935770E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.784600E-01 |
| Extreme_Weight-vs-Obese |
3.854600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.155800E-01 |
| Obese-vs-Extreme_Obese |
5.348400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.164500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.55400000037653E-07 |
| Normal-vs-Age(61-80Yrs) |
3.921400E-03 |
| Normal-vs-Age(81-100Yrs) |
6.195000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.522400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.783800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.196000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.486440E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.475650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.146600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.07200001600683E-09 |
| Normal-VS-Type2 PRCC |
6.798800E-01 |
| Normal-VS-KIRP CIMP |
4.497400E-01 |
| Normal-VS-Unclassified PRCC |
7.243800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.38329999677111E-08 |
| Type1 PRCC-VS-KIRP CIMP |
9.397600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.414200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.072000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.238100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.469800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.033000E-01 |
| Normal-vs-N1 |
3.246300E-02 |
| Normal-vs-N2 |
8.494800E-01 |
| N0-vs-N1 |
1.269150E-01 |
| N0-vs-N2 |
7.437400E-01 |
| N1-vs-N2 |
2.872000E-01 |
|
|
